Day: April 29, 2021
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MONTRÉAL, April 29, 2021 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Corporation” or “Osisko Metals“) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce that it has closed its previously-announced brokered private placement, pursuant to which the Corporation sold an aggregate of 12,000,000 common shares of the Corporation that will qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) (“Flow-Through Shares“) at a price of C$0.50 per Flow-Through Share for aggregate gross proceeds of C$6,000,000, including the exercise in full of the agent’s option (the “Offering“).
The Offering was led by Haywood Securities...
Šiaulių bankas will hold an Investor Conference Webinar to introduce the financial results for 1Q 2021 and recent developments
Written by Customer Service on . Posted in Public Companies.
Šiaulių Bankas AB, company code 112025254, address of the head office Tilžės str. 149, Šiauliai, Lithuania.
AB Šiaulių bankas invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the May 5, 2021 at 4 pm (EET). The presentation will be held in English.
The webinar will be hosted by Vytautas Sinius, CEO and Donatas Savickas, CFO who will introduce the Bank’s financial results for the 1 quarter of 2021 and recent developments, as well participants questions will be answered.
After the presentation investors are welcome to ask questions. Due to limited webinar time, we encourage participants to send their questions before the webinar until May 4 to emilija.ivanauskaite@nasdaq.com.
How to join the webinar?
To join the webinar, please register via following link:https://attendee.gotowebinar.com/register/1038464957773628427....
Robex: Outstanding 2020 Balance Sheet, Operating Income Up 126% and Mine Life Extended to Over 10 Years
Written by Customer Service on . Posted in Public Companies.
QUEBEC CITY, April 29, 2021 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex“, “the Group” or “the Company“) (TSXV: RBX/FWB: RB4) is pleased to publish their financial results for the year ending December 31, 2020 and their production results for the first quarter of 2021.
All amounts are in Canadian dollars (CAD).
Highlights for the Year 202022% INCREASE IN REVENUEGold sales of $120.8 million compared to $99.2 million in 2019.126% INCREASE IN OPERATING INCOMEOperating income of $48.5 million compared to $21.4 million in 2019, including respectively $20.9 million and $31.6 million of depreciation and amortization of tangible assets.28% INCREASE IN CASH FLOWS FROM OPERATING ACTIVITIESiCash flows from operating activitiesi of $65.1 million or $0.111 per shareii compared to $51 million or...
Morphic Announces Corporate Highlights and First Quarter 2021 Financial Results
Written by Customer Service on . Posted in Public Companies.
Expanded research and development collaboration with Janssen for third integrin program
Announced positive preliminary results from Phase 1 SAD clinical trial of MORF-057
Received acceptance to present full MORF-057 Phase 1 data set at the ECCO’21 Virtual Congress in July
Completed $245 million upsized public offering of stock
Presented positive preclinical data from αvβ8 program at AACR Annual Meeting demonstrating anti-tumor activity in checkpoint refractory cancer models
WALTHAM, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the first quarter of 2021.
Recent Highlights and OutlookExpanded research and development...
Brickell Biotech to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13, 2021
Written by Customer Service on . Posted in Public Companies.
BOULDER, Colo., April 29, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it will report its financial results for the first quarter ended March 31, 2021, after the market close on Thursday, May 13, 2021. Brickell’s management will host a conference call and webcast at 4:30 pm ET on Thursday, May 13th to discuss the financial results and recent corporate highlights.
To access the call, please dial 877-705-6003 in the U.S. or 201-493-6725 outside the U.S. and provide the conference ID number: 13718897. To access the live webcast, please go to the Investors section of Brickell’s website at https://ir.brickellbio.com/events-presentations....
VVC Exploration Adds New Property in Colorado, Further Growing Helium Portfolio
Written by Customer Service on . Posted in Public Companies.
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — VVC Exploration Corporation (“VVC” or the “Company“) (TSX-V:VVC) announces the addition of a new gas property in its wholly owned subsidiary, Plateau Helium Corporation (“PHC”), a Wyoming corporation. The transaction bolsters VVC’s helium portfolio and its ability to capitalize on the growing demand for helium, driven by increased global usage.
The property, known as the Syracuse Extension 1, was purchased at a nominal cost and a commitment to commence production, with the seller retaining a 2% royalty in the property. In addition to the 2% royalty, standard industry royalties of 12.5% are payable to arm’s length land owners from the proceeds of any production. PHC owns a 100% operated working interest in the Syracuse Extension 1 lease subject...
ORBCOMM Announces First Quarter 2021 Results
Written by Customer Service on . Posted in Public Companies.
– Total Revenues of $63.7 Million, In Line with Guidance –– 87,000 Devices Shipped Drives Product Sales Growth –– Company Adds 50,000 Net Subscribers in Q1 Bringing Total Subscribers to 2.28 Million –
ROCHELLE PARK, N.J., April 29, 2021 (GLOBE NEWSWIRE) — ORBCOMM Inc. (NASDAQ: ORBC), a global provider of Internet of Things (IoT) solutions, today announced financial results for the first quarter ended March 31, 2021.
The following financial highlights are in thousands of dollars and unaudited.
Three Months Ended
March 31,
2021
2020Recurring Service Revenues
$
36,241
$
39,853
Other Service Revenues
1,509
671
Total Service Revenues
37,750
40,524
Product Sales
25,945
25,655
Total Revenues
63,695
66,179
Net Loss Attributable to ORBCOMM Inc. Common Stockholders
(10,574
)
(6,975
)Adjusted...
Vaxart to Present at the World Vaccine Congress Washington 2021
Written by Customer Service on . Posted in Public Companies.
SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the upcoming World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.
Dr. Tucker’s presentation titled, “Vaxart oral COVID-19 vaccine; hold the ice and the needles,” will provide insight into the Company’s response and approach to addressing the COVID-19 pandemic with a room temperature oral tablet vaccine that is potentially protective against new and emerging COVID-19 strains.
Presentation details are as follows:Title: Vaxart oral COVID-19 vaccine; hold the ice and the needlesTrack:...
BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, April 29, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that it has applied for patent protection of its novel implantable subcutaneous product and its use in the prevention of psychedelic drug diversion.
LSD and psilocybin microdosing are currently in multiple ongoing clinical trials. One major overlooked issue is the possibility of the patient consuming a full psychedelic dose of psilocybin or LSD as opposed to the prescribed microdose or resale of the drugs to someone other than the patient. BetterLife’s invention has solved this problem by use of an implant administered...
Apria to Announce First Quarter 2021 Financial Results
Written by Customer Service on . Posted in Public Companies.
INDIANAPOLIS, April 29, 2021 (GLOBE NEWSWIRE) — Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will release fiscal first quarter 2021 financial results on Thursday, May 13, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Conference Call Details
The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5247226; or via a live audio webcast that will be available online at https://ir.apria.com/.
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Apria
Apria is a leading...